Lifecore Biomedical, Inc. \De\ Q3 FY2021 Earnings Call

Lifecore Biomedical, Inc. \De\ (LFCR)

Earnings Call FY2021 Q3 Call date: 2021-04-07 Concluded

Quarter scorecard

Revenue

$27.81M

-81.8% YoY

Diluted EPS

$-0.24

Gross margin

39.3%

+26.2 pp YoY

Net income

-$6.98M

Belgium $6.00M

-35.5%

All Other Countries $3.90M

+3800%

Canada $2.70M

-86.2%

Switzerland $1.60M

+433.3%

United Kingdom $1.20M

+500%

Czechia $800,000

-61.9%

Ireland $300,000